Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Debt / NOTE 0.625% 4/0
-
Number of holders
-
41
-
Total 13F principal, excl. options
-
352,061,084
-
Principal change
-
+46,458,996
-
Total reported value, excl. options
-
$324,909,891
-
Value change
-
+$43,301,590
-
Number of buys
-
14
-
Number of sells
-
11
-
Price
-
$0.9223
Institutional Holders of SUPERNUS PHARMACEUTICALS INC - NOTE 0.625% 4/0 as of Q3 2020
As of 30 Sep 2020 SUPERNUS PHARMACEUTICALS INC - NOTE 0.625% 4/0 had 41 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $352,061,084 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included CAMDEN ASSET MANAGEMENT L P /CA, ADVENT CAPITAL MANAGEMENT /DE/, Opti Capital Management, LP, Radcliffe Capital Management, L.P., JPMORGAN CHASE & CO, WOLVERINE ASSET MANAGEMENT LLC, Invesco Ltd., Polar Capital LLP, AMUNDI PIONEER ASSET MANAGEMENT INC, and GOLDMAN SACHS GROUP INC.
This table shows 42 bond principal holders of the security as of 30 Sep 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.